Veeva Systems Inc. (VEEV) Launches eSource to Streamline Clinical Trial Data

The 5th banal connected our database of best concern stocks is Veeva Systems Inc. (NYSE:VEEV).

TheFly reported connected February 20 that UBS reduced its terms people connected VEEV to $200 from $280 portion maintaining a Neutral standing connected the stock.

Veeva Systems Inc. (NYSE:VEEV) made a important announcement connected January 29 erstwhile it unveiled Veeva eSource, a caller exertion wrong its SiteVault level designed to amended information accuracy and trim manual operations successful objective trials.

The solution enables nonstop integer seizure of proceedings accusation astatine probe sites, removing reliance connected insubstantial records. It integrates with physics wellness records to transportation applicable diligent information and connects with physics information seizure systems to automate information travel to sponsors. By minimizing duplicate introduction and eliminating traditional root information verification processes, the exertion is designed to little administrative burden, alteration errors, and accelerate survey execution. Veeva eSource besides features unfastened API connectivity and is expected to go disposable to aboriginal adopters successful the 2nd fractional of 2026.

Moreover, connected February 11, VEEV announced it volition merchandise its fiscal 2026 4th fourth and full-year fiscal results connected March 4, 2026.

Veeva Systems Inc. (NYSE:VEEV) provides cloud-based bundle solutions for the beingness sciences industry, supporting cause development, regulatory compliance, and commercialized operations.

While we admit the imaginable of VEEV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.

Disclosure: None. Follow Insider Monkey connected Google News.